000			02195 a2200529 4500
005			20250515030447.0
264		0	_c20060727
008			200607s 0 0 eng d
022			_a0008-5472
024	7		_a10.1158/0008-5472.CAN-05-4048 _2doi
040			_aNLM _beng _cNLM
100	1		_aQi, Huiling
245	0	0	_aSynergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. _h[electronic resource]
260			_bCancer research _cJun 2006
300			_a5875-82 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAcetylation _xdrug effects
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aCHO Cells
650	0	4	_aCarrier Proteins _xbiosynthesis
650	0	4	_aCricetinae
650	0	4	_aDrug Synergism
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aFolate Receptors, GPI-Anchored
650	0	4	_aFolic Acid Antagonists _xadministration & dosage
650	0	4	_aHistone Deacetylase Inhibitors
650	0	4	_aHistones _xmetabolism
650	0	4	_aHumans
650	0	4	_aHydroxamic Acids _xadministration & dosage
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aPromoter Regions, Genetic _xdrug effects
650	0	4	_aRNA, Messenger _xbiosynthesis
650	0	4	_aReceptors, Cell Surface _xbiosynthesis
650	0	4	_aReceptors, Immunologic _xmetabolism
650	0	4	_aReceptors, Retinoic Acid _xbiosynthesis
650	0	4	_aSubstrate Specificity
650	0	4	_aTetrahydrofolates _xadministration & dosage
650	0	4	_aTranscription Factor AP-1 _xmetabolism
650	0	4	_aTretinoin _xadministration & dosage
650	0	4	_aUp-Regulation _xdrug effects
650	0	4	_aValproic Acid _xadministration & dosage
700	1		_aRatnam, Manohar
773	0		_tCancer research _gvol. 66 _gno. 11 _gp. 5875-82
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-05-4048 _zAvailable from publisher's website
999			_c16337413 _d16337413